Health problems of newly arrived migrants and refugees in Europe

Journal of Travel Medicine

Volumn 24, Issue 4, 2017, Pages

  Pavli, Androula ^a   Maltezou, Helena ^a  

^a Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

Health; Migrants; Problems; Refugees

Indexed keywords

ALLERGIC REACTION; CULTURAL FACTOR; DIABETES MELLITUS; EPIGASTRIC PAIN; ERYTHEMA; EUROPE; FEVER; FROSTBITE; GASTROENTERITIS; GASTROINTESTINAL INFECTION; GYNECOLOGIC DISEASE; HEADACHE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH STATUS; HEART DISEASE; HUMAN; IMMIGRATION; LEGAL ASPECT; MENTAL DISEASE; METABOLIC DISORDER; MIGRANT; MORBIDITY; REFUGEE; REFUGEE CAMP; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATIC DISEASE; SKIN INFECTION; SOCIAL PROBLEM; SOCIAL WORK; TOOTH DISEASE; TRAVEL; UROGENITAL TRACT DISEASE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; EMPORIATRICS; HEALTH CARE DELIVERY; HEALTH SERVICE;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; EMIGRANTS AND IMMIGRANTS; EUROPE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; REFUGEES; TRAVEL MEDICINE;

EID: 85020412124     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1093/jtm/tax016     Document Type: Review

References (73)

1. Global Migration Data Analysis Centre. http://iomgmdac.org/. [Accessed 18/10/2016].
2. EUROSTAT. Migration and Migrant Population Statistics. http://ec.europa.eu/eurostat/statistics-explained/index.php/Migration_and_migrant_population_statistics. [Accessed 18/10/2016].
3. United Nations High Commissioner for Refugees. http://www. unhcr.org/global-trends-2015.html. [Accessed 18/10/2016].
4. Hellenic Police. Data base. http://www.astynomia.gr/index.php?option=ozo_content&lang=%27.%27&perform=view&id=55858& Itemid=1240&lang=. [Accessed 18/10/2016].
5. Migrant Health for the Benefit of All, MC/INF/275, IOM, Geneva, 2004.
6. Migration and Health in the European Union. http://www.euro.who.int/__data/assets/pdf_file/0019/161560/e96458.pdf?ua=1. [Accessed 18/10/2016].
7. World Health Organisation (WHO). Migrants: The Way Forward-Report of a Global Consultation. Madrid, Spain, 3-5 March 2010.
8. Lenz K, Bauer-Dubau K, Jelinek T. Delivery of medical care for migrants in Germany: delay of diagnosis and treatment. J Travel Med 2006; 13: 133-7.
9. Affronti M, Affronti A, Pagano S et al. The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine. Int Emerg Med 2011; 7: 561-6.
10. Firenze A, Restivo V, Bonanno V et al. Health status of immigrants arrived to Italian coast. Epidemiol Prev 2014; 38: 78-82.
11. Castañeda H. Illegality as risk factor: a survey of unauthorized migrant patients in a Berlin clinic. Soc Sci Med 2009; 68: 1552-60.
12. Yun K, Hebrank K, Graber LK et al. High prevalence of chronic noncommunicable conditions among adult refugees: implications for practice and policy. J Community Health 2012; 5: 1110-8.
13. Redditt VJ, Janakiram P, Graziano D, Rashid M. Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases. Can Fam Physician 2015; 7: e303-9.
14. Redditt V, Graziano Janakiram P, Rashid M. Health status of newly arrived refugees in Toronto, Ont: Part 2: chronic diseases. Can Fam Physician 2015; 61: e310-5.
15. Economopoulou A, Pavli A, Stasinopoulou P et al. Migrant screening: Lessons learned from the migrant holding level at the Greek-Turkish borders. J Infect Public Health 2016 May 5. pii: S1876-0341(16)30030-2.
16. Bo A, Zinckernagel L, Krasnik A et al. Coronary heart disease incidence among non-Western immigrants compared to Danish-born people: effect of country of birth, migrant status, and income. Eur J Prev Cardiol 2015; 2: 1281-9.
17. Agyemang C, Bhopal R. Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin White people? A review of cross-sectional data. J Hum Hypertens 2003; 17: 523-34.
18. Abouzeid M, Philpot B, Janus ED et al. Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia. BMC Public Health 2013; 13: 252.
19. Vandenheede H, Deboosere P, Stirbu I et al. Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change. Eur J Epidemiol 2012; 27: 109-17.
20. Arnold M, Aarts MJ, van der AaMet al. Investigating cervical, oesophageal and colon cancer risk and survival among migrants in The Netherlands. Eur J Public Health 2013; 5: 867-73.
21. Arnold M, Razum O, Coebergh JW. Cancer risk diversity in nonwestern migrants to Europe: an overview of the literature. Eur J Cancer 2010; 46: 2647-59.
22. Reeves M, de Wildt G, Murshali H et al. Access to health care for people seeking asylum in the UK. Br J Gen Pract 2006; 525: 306-8.
23. Ager A. Health and forced migration. In: Fiddian-Qasmiyeh E, Loescher G, Long K, Sigona N (eds). The Oxford Handbook of Refugee and Forced Migration Studies. Oxford: Oxford University Press, 2014.
24. De Vito E, de Waure C, Specchia ML, Ricciardi W. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Undocumented Migrants in the European Region. Copenhagen: WHO Regional Office for Europe; 2015. WHO Health Evidence Network Synthesis Reports. https://www.ncbi.nlm.nih. gov/pubmed/27536764. [accessed 18/10/2016].
25. World Health Organization. Migration and Health: Key Issues. http://www.euro.who.int/en/health-topics/health-determinants/mi gration-and-health/migrant-health-in-the-european-region/migra tion-and-health-key-issues#292115. [Accessed 18/10/2016].
26. Keygnaert I, Vettenburg N, Temmerman M. Hidden violence is silent rape: sexual and gender-based violence in refugees, asylum seekers and undocumented migrants in Belgium and the Netherlands. Cult Health Sex 2012; 14: 505-20.
27. Migrant Health and the Right to Health in Europe. http://www.mi grant-health-europe.org/files/Right%20to%20Health_Background %20Paper.pdf. [Accessed 18/10/2016].
28. Hermansson A-C, Timpka T, Thyberg M. The long-termimpact of torture on themental health of war-wounded refugees: findings and implications for nursing programmes. Scand J Caring Sci 2003; 4: 317-24.
29. Masmas TN, Møller E, Buhmannr C et al. Asylum seekers in Denmark: a study of health status and grade of traumatization of newly arrived asylum seekers. Torture 2008; 2: 77-86.
30. Roth G, Ekblad S. A longitudinal perspective on depression and sense of coherence in a sample of mass-evacuated adults from Kosovo. J Nerv Ment Dis 2006; 5: 378-81.
31. Mertens E, Rockenschaub G, Economopoulou A, Kreidl P. Assessment of public health issues of migrants at the Greek-Turkish border, April 2011. Euro Surveill 2012; 2: pii: 20056.
32. Jablonka A, Solbach P, Happle C et al. Hepatitis A immunity in refugees in Germany during the current exodus. Med Klin Intensivmed Notfmed 2016 (Epub ahead of print).
33. Hellenic Center for Disease Control and Prevention. Epidemiological Surveillance at Points of Care in Refugees/Migrants. www.keelpno.gr. [Accessed 19/10/2016].
34. Jablonka A, Solbach P, Nothdorft S et al. Low seroprevalence of syphilis and HIV in refugees and asylum seekers in Germany in 2015. Dtsch MedWochenschr 141; 14: e128-32.
35. Vorou R, Remoudaki HD, Maltezou HC. Nosocomial scabies. J Hosp Infect 2007; 1: 9-14.
36. European Center for Disease Control and Prevention. Infectious Diseases of Specific Relevance to Newly-Arrived Migrants in the EU/EEA. http://ecdc.europa.eu/en/publications/Publications/Infectiousdiseases-of-specific-relevance-to-newly-arrived-migrants-in-EUEEA. pdf. [Accessed 20/10/2016].
37. World Health Organization. The Global Prevalence of Hepatitis A Virus Infection and Susceptibility: A Systematic Review. 2010. http://apps.who.int/iris/bitstream/10665/70180/1/WHO_IVB_10.01_eng. pdf. [Accessed 20/10/2016].
38. World Health Organization. Global Health Atlas. http://apps.who. int/globalatlas/. [Accessed 20/10/2016].
39. World Health Organization Regional Office for the Eastern Mediterranean. WHO Eastern Mediterranean Region: Framework for Health Information Systems and Core Indicators for Monitoring Health Situation and Health System Performance. http://applica tions.emro.who.int/dsaf/EMROPUB_2014_EN_1792.pdf?ua=1. [Accessed 20/10/2016].
40. Kimbrough W, Saliba V, Dahab M et al. The burden of tuberculosis in crisis-affected populations: a systematic review. Lancet Infect Dis 2012; 12: 950-65.
41. Sandgren A, Schepisi MS, Sotgiu G et al. Tuberculosis transmission between foreign-and native-born populations in the EU/EEA: a systematic review. Eur Respir J 2014; 43: 1159-71.
42. European Center for Disease Control and Prevention. HIV/AIDS Surveillance in Europe 2015. http://ecdc.europa.eu/en/publications/ Publications/HIV-AIDS-surveillance-Europe-2015.pdf. [Accessed 16/1/2016].
43. Fakoya I, Álvarez-Del Arco D, Monge S. Advancing migrant access to health services in Europe (AMASE): protocol for a cross-sectional study. JMIR Res Protoc 2016; 5: e74. doi: 10.2196/resprot.5085.
44. Rossi C, Shrier I, Marshall L et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One 2012; 9: e44611.
45. Greenaway C, Thu Ma A, Kloda LA et al. The seroprevalence of hepatitis C antibodies in immigrants and refugees from intermediate and high endemic countries: a systematic review and meta-analysis. PLoS One 2015; e0141715.
46. Gergely A, Bechet S, Goujon C et al. Hepatitis B screening in travelers: a retrospective analysis. Travel Med InfectDis 2014; 12: 707-12.
47. Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vaccin Immunother 2015; 11: 2627-36.
48. Jones G, Haeghebaert S, Merlin B et al. Measles outbreak in a refugee settlement in Calais, France: January to February 2016. Euro Surveill 2016; 11: 3.
49. Cadieux G, Redditt V, Graziano D, Rashid M. Risk factors for varicella susceptibility among refugees to Toronto, Canada. J Immigr Minor Health 2015 (in press).
50. de Valliere S, Cani N, Grossenbacher M et al. Comparison of two strategies to prevent varicella outbreaks in housing facilities for asylum seekers. Int J Infect Dis 2011; 15: e716-21.
51. Danis K, Baka A, Lenglet A et al. Autochthonous Plasmodium vivax malaria in Greece, 2011. J Euro Surveill 2011; 20;pii: 1993.
52. Access to health care for undocumented migrants in Europe. Brussel: Platform for International Cooperation on Undocumented Migrants (PICUM); 2007
53. Rechel B, Mladovsky P, Devillé W et al (eds). Migration and Health in the European Union. Maidenhead, UK: Open University Press for the European Observatory on Health Systems and Policies, 2011
54. Harding S, Teyhan A, Rosato M, Santana P. All cause and cardiovascular mortality in African migrants living in Portugal: evidence of large social inequalities. Eur J Cardiovasc Prev Rehabil 2008; 15: 670-6.
55. Maltezou HC. Antibiotic resistance and the refugee crisis in Europe-preemptive action is indicated. Travel Med Infect Dis 2016; 2: 69-70.
56. Norredam M, Mygind A, Krasnik A. Access to healthcare for asylum seekers in the European Union—a comparative study of country policies. Eur J Public Health 2005; 3: 285-9.
57. United Nations High Commissioner for Refugees (UNHCR). 1951 UNHCR Convention on the Status of Refugees [Internet]. Geneva: UHNCR. http://www.unhcr.org/pages/49da0e466.html. [Accessed 24/10/2016].
58. World Health Organization (WHO). WHO/Europe Supports Member States in Strengthening Public Health Evidence-Informed Policies for Migrants and Refugees Copenhagen: WHO Regional Office for Europe; 2015. http://www.euro.who.int/en/media-centre/ events/events/2015/11/high-level-meeting-on-refugee-and-migranthealth/ news/news/2015/10/whoeurope-supports-member-states-instrengthening-public-health-evidence-informed-policies-for-refu gees-and-migrants. [Accessed 24/10/2016].
59. Bozorgmehr K, Razum O. Effect of restricting access to health care on health expenditures among asylum-seekers and refugees: a quasi-experimental study in Germany, 1994-2013. PLoS One 2015; 7
60. Bradby H, Humphris R, Newall D, Phillimore J. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. Copenhagen: WHO Regional Office for Europe; 2015. WHO Health Evidence Network Synthesis Reports.
61. European Center for Disease Control and Prevention. Rapid Risk Assessment: Communicable Disease Risks Associated with the Movement of Refugees in Europe During the Winter Season. http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_Disp Form.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID= 1401. [Accessed 24/10/2016].
62. Pareek M, Watson JP, Ormerod LP et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011; 6: 435-44.
63. Veldhuijzen IK, Toy M, Hahne SJ et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology 2010; 2: 522-30.
64. Kärki T, Napoli C, Riccardo F et al. Screening for infectious diseases among newly arrived migrants in EU/EEA countries-varying practices but consensus on the utility of screening. Int J Environ Res Public Health 2014; 11: 11004-14.
65. Center for Disease Control and Prevention. Guidelines for the U.S. Domestic Medical Examination for Newly Arrived Refugees. https:// www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domes tic-guidelines.html. [Accessed 18/1/2017].
66. Center for Disease Control and Prevention. Screening for Hepatitis B During the Domestic Medical Examination. https://www.cdc.gov/ immigrantrefugeehealth/guidelines/domestic/hepatitis-screeningguidelines. html. [Accessed 18/1/2017].
67. Pottie K, Greenaway C, Feightner J et al. Evidence based clinical guidelines for immigrants and refugees. CMAJ 2011; 183: E824-925.
68. Hahné SJ, Veldhuijzen IK, Wiessing L et al. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and costeffectiveness of screening. BMC Infect Dis 2013; 13: 181.
69. Deblonde J, Sasse A, Del Amo J et al. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA. BMC Public Health 2015; 15: 1228. doi: 10.1186/s12889-015-2571-y.
70. Hatzakis A, Van Damme P, Alcorn K et al. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat 2013; 20(Suppl 2): 1-20.
71. Miller JM, Boyd HA, Ostrowski SR et al. Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. Am J TropMedHyg 2000; 62: 115-21.
72. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 1999; 340: 773-9.
73. Zammarchi L, Casadei G, Strohmeyer M et al. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries. BMC Health Serv Res 2015; 15: 412.